Atugen Gives Update on Cancer Drugs; Firm Aims To Be First in Clinic as Phase I Is Set for 1H 2007

Atugen expects to begin phase I testing of its pancreatic cancer drug candidate in the first half of next year, while a phase I trial in lung cancer will start during the second half of the year.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.